Technology

Canon Healthcare announces new subsidiary in a bid to expand presence in the U.S.

Japanese tech giant Canon has announced the opening of its second med tech-focused subsidiary in the U.S., with the first being Canon...

Agreement for the commercialization of mammography AI reached between iCAD and Google Health

A deal was penned between medical tech company iCAD and Google Health to use Google’s AI technology in iCAD’s breast imaging solutions....

Ionis And Metagenomi Team Up For Ambitious Genetic Targeting Pact

Ionis Pharmaceuticals and startup gene editing firm Metagenomi have just signed a multi-target research deal that has the potential to generate nearly...

BioMed X and Sanofi join hands to use AI for drug development

The failure of new drug therapy candidates in the clinical development process has plagued the pharmaceutical industry for some time now. The...

Scribe partners with Sanofi for cancer treatment development

Scribe Therapeutics and Sanofi have formed a strategic alliance to help move the development of clustered regularly interspaced short palindromic repeats (CRISPR)-based...

Zealand Pharma and Iktos collaborate to develop AI Technology for Peptide drug design

Specialists in artificial intelligence for new drug design, Iktos announced a research partnership with Zealand Pharma to jointly develop predictive and generative...

Meta Pharmaceutical secures $15 million investment to fund artificial intelligence-based autoimmune treatment

Meta Pharmaceuticals is a Chinese Biotechnology company that has recently completed its pre-A and seed rounds. The company has managed to raise...

Catalent and MigVax reach an agreement to develop an oral vaccine for Covid-19

Catalent, a pharmaceutical company based in Somerset, New Jersey has reached an agreement with MigVax, an Israel-based biopharmaceutical firm. The agreement enables...

Latest news

FDA and CDC exploring unlikely relation between COVID-19 vaccine and stroke

The FDA and CDC have brought out new revelations that the revised COVID-19 injection from Pfizer Inc...

Disappointing sales prompt AstraZeneca to pull out leukemia drug Lumoxiti from U.S. market

In a letter shared with healthcare providers, AstraZeneca has announced that it will be pulling its leukemia...

Sanofi’s Venture Capital units to receive over $750 million in investment to boost firm’s investment capabilities 

After a successful last year in which Sanofi Ventures made its second-highest number of deals, 10 rounds...

Must read

Surrounded by controversy, FDA approves Biogen’s Alzheimer’s drug Aduhelm

In the middle of the debate about the Alzheimer’s drug approval, the United States FDA has authorized Aduhelm

Amgen’s KRAS drug gets early FDA approval for lung cancer with specific mutation

On Friday, the United States FDA (Food and Drug Administration) has authorized a medication of Amgen Biopharmaceutical in patients with NSCLC

You might also likeRELATED
Recommended to you